RESFLU-S-125 | Fluticasone Propionate & Salmeterol Inhaler IP
RESFLU-S-125 is a combination inhaler containing Fluticasone Propionate, a powerful corticosteroid, and Salmeterol, a long-acting beta-agonist (LABA). This dual-action inhaler is specifically designed for the management and prevention of asthma and chronic obstructive pulmonary disease (COPD).
- Fluticasone Propionate: Minimizes airway inflammation, reducing the frequency and severity of symptoms such as wheezing and breathlessness.
- Salmeterol: Provides prolonged bronchodilation, ensuring effective airflow and relief from bronchospasms for up to 12 hours.
Dosage and Administration
- Inhale two puffs daily or as prescribed by your healthcare provider.
- Ensure correct inhalation technique for optimal results.